Literature DB >> 34950338

Meta-Analysis of Catheter Ablation Compared with Drug Therapy as First Line Treatment Strategy of Paroxysmal Atrial-Fibrillation.

Ashish Kumar1, Ahmad Al-Abdouh2, Harshvardhan Zala3, Ahmad Jabri4, Awani Deshmukh5, Abhishek Deshmukh5.   

Abstract

Entities:  

Keywords:  Atrial Fibrillation; Catheter ablation; Drug Therapy; First line therapy

Year:  2021        PMID： 34950338      PMCID： PMC8691348          DOI： 10.4022/jafib.2464

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


× No keyword cloud information.
  7 in total

1.  Secular trends in the prevalence of atrial fibrillation: The Framingham Study.

Authors:  P A Wolf; E J Benjamin; A J Belanger; W B Kannel; D Levy; R B D'Agostino
Journal:  Am Heart J       Date:  1996-04       Impact factor: 4.749

2.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

Authors:  Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

3.  Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.

Authors:  Jens Cosedis Nielsen; Arne Johannessen; Pekka Raatikainen; Gerhard Hindricks; Håkan Walfridsson; Ole Kongstad; Steen Pehrson; Anders Englund; Juha Hartikainen; Leif Spange Mortensen; Peter Steen Hansen
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

4.  Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.

Authors:  Paulus Kirchhof; A John Camm; Andreas Goette; Axel Brandes; Lars Eckardt; Arif Elvan; Thomas Fetsch; Isabelle C van Gelder; Doreen Haase; Laurent M Haegeli; Frank Hamann; Hein Heidbüchel; Gerhard Hindricks; Josef Kautzner; Karl-Heinz Kuck; Lluis Mont; G Andre Ng; Jerzy Rekosz; Norbert Schoen; Ulrich Schotten; Anna Suling; Jens Taggeselle; Sakis Themistoclakis; Eik Vettorazzi; Panos Vardas; Karl Wegscheider; Stephan Willems; Harry J G M Crijns; Günter Breithardt
Journal:  N Engl J Med       Date:  2020-08-29       Impact factor: 91.245

5.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.

Authors:  Carlos A Morillo; Atul Verma; Stuart J Connolly; Karl H Kuck; Girish M Nair; Jean Champagne; Laurence D Sterns; Heather Beresh; Jeffrey S Healey; Andrea Natale
Journal:  JAMA       Date:  2014-02-19       Impact factor: 56.272

6.  Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.

Authors:  Jason G Andrade; George A Wells; Marc W Deyell; Matthew Bennett; Vidal Essebag; Jean Champagne; Jean-Francois Roux; Derek Yung; Allan Skanes; Yaariv Khaykin; Carlos Morillo; Umjeet Jolly; Paul Novak; Evan Lockwood; Guy Amit; Paul Angaran; John Sapp; Stephan Wardell; Sandra Lauck; Laurent Macle; Atul Verma
Journal:  N Engl J Med       Date:  2020-11-16       Impact factor: 91.245

7.  Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation.

Authors:  Oussama M Wazni; Gopi Dandamudi; Nitesh Sood; Robert Hoyt; Jaret Tyler; Sarfraz Durrani; Mark Niebauer; Kevin Makati; Blair Halperin; Andre Gauri; Gustavo Morales; Mingyuan Shao; Jeffrey Cerkvenik; Rachelle E Kaplon; Steven E Nissen
Journal:  N Engl J Med       Date:  2020-11-16       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.